eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2011
vol. 15
 
Share:
Share:
abstract:
Case report

Radiation recall dermatitis induced by Amol during tamoxifen therapy – case report

Aleksander Obtułowicz
,
Magdalena Pirowska
,
Agnieszka Kosiniak-Kamysz

Współcz Onkol 2011; 15 (3): 168–171
Online publish date: 2011/07/04
View full text Get citation
 
PlumX metrics:
In the course of radiation therapy different types of adverse reactions of the skin are observed in approximately 95% of patients. Among the various complications encountered after radiotherapy, radiation recall dermatitis (RRD) deserves special attention. Radiation dermatitis is a form of delayed hypersensitivity of irradiated skin, and the direct trigger factors are medicines – most chemotherapeutics. The reaction is an inflammatory dermatosis. It is limited to previously irradiated skin and appears a number of months after radiotherapy. The aetiology of RRD is still unclear. Its clinical presentation may vary from mild erythema to necrosis and ulceration. The article presents the case of a 50-year-old patient, who after radiotherapy for breast cancer, during the hormonal therapy (tamoxifen), developed RRD type skin reactions after skin application of Amol. The article presents a detailed differential diagnosis of skin changes of RRD type, and discusses the principles of treatment and prevention.
keywords:

radiation recall dermatitis, tamoxifen, Amol, breast cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.